Intelligence · Clinical Development
Pipeline search results
Programs matching “breast-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 272 pipeline programs matching "breast-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Entinostat
Syndax Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Etrumadenant
Arcus Biosciences
TNBC - Triple-Negative Breast Cancer
1 trial -
FPA150
Prime Medicine
Breast Cancer
1 trial -
HER-2/neu peptide vaccine
Marker Therapeutics
HER2-positive Breast Cancer
1 trial -
INO-1400
INOVIO PHARMACEUTICALS, INC.
Breast Cancer
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Breast Cancer
1 trial -
Iopofosine I 131
Cellectar Biosciences
Breast Cancer
1 trial -
Ipatasertib
Hoffmann-La Roche
Breast Cancer
1 trial -
Letrozole
Context Therapeutics
Metastatic Breast Cancer
1 trial -
Mammaglobin-A DNA Vaccine
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Mifepristone and Eribulin in combination
CORCEPT THERAPEUTICS INC
Breast Cancer
1 trial -
NP-G2-044
BRIGHT MINDS BIOSCIENCES INC.
Breast Cancer
1 trial -
OP-3136
Olema Pharmaceuticals
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)
1 trial -
PRT3645
Prelude Therapeutics Inc
Breast Cancer
1 trial -
PTC299
PTC THERAPEUTICS, INC.
Metastatic Breast Cancer
1 trial -
PV-10 (rose bengal disodium 10%)
PROVECTUS BIOPHARMACEUTICALS, INC.
Breast Cancer
1 trial -
PVSRIPO
United Therapeutics Europe Ltd
Invasive Breast Cancer
1 trial -
Palazestrant
Olema Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Pegfilgrastim
Biotech Pharmaceutical Co.,
Breast Cancer
1 trial -
Pelareorep
ONCOLYTICS BIOTECH INC
Breast Cancer
1 trial -
Proxalutamide
The First People's Hospital of Lianyungang
Metastatic Breast Cancer
1 trial -
Pyrotinib low dose group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
SNDX-275
Syndax Pharmaceuticals
Breast Cancer
1 trial -
SPARC1210
Advanced Accelerator Applications
Breast Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.